OR WAIT 15 SECS
(TAMPA, FLORIDA, USA, 10 FEBRUARY 2009)-ISPE, a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, announced today that it will host a live, one-hour Webinar titled, ”Use of IVR to Support Elimination of Use-by Dates from Clinical Trial Labels,” on Thursday, 26 February.
Michael Arnold, Business Process Head for Pfizer, and Christine Milligan, Director of Client Services for Fisher Clinical Services, will discuss the possibility of eliminating use-by dates on Investigational Medicinal Product (IMP) labels to reduce costs and minimize patient risk by using Interactive Voice Response (IVR) technology while still remaining in compliance with European Union directives.
“ISPE is excited to provide this unique educational opportunity about how technology can reduce costs for the pharmaceutical industry and minimize risk for patients, while using cutting-edge technology to deliver that message,” said Robert P. Best, ISPE President and CEO.
The presentation will review the activities and conclusions of the Label Task Team, feedback from competent authorities to date, identification of related reference documents, and the next steps toward broader application. Additionally, the session will review parts of the draft whitepaper and updates to risk analysis report comparing the use of IVR versus conventional packaging for managing use-by dates.
Attendance is recommended for investigational product planners, project managers, packaging professionals, contract service providers, clinical trial/supply chain professionals, clinical supply and quality control personnel, and regulatory chemistry and manufacturing controls personnel.
For more information about, or to register for, this event, visit ISPE’s online registration page for the IVR webinar.
ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 25,000 pharmaceutical science and manufacturing professionals in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE has worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; its Asia Pacific office in Singapore; and its newly established office in Shanghai, China. Visit www.ISPE.org for additional Society news and information.